Schizophrenia is a serious and disabling mental disorder with symptoms such as auditory hallucinations, disordered thinking and delusions, avolition, anhedonia, blunted affect and apathy. In this review article we seek to present the current scientific findings from linkage studies and susceptible genes and the pathophysiology of white matter in schizophrenia. The article has been reviewed in two parts. The first part deals with the linkage studies and susceptible genes in schizophrenia in order to have a clear-cut picture of the involvement of chromosomes and their genes in schizophrenia. The genetic linkage results seem to be replicated in some cases but in others are not. From these results, we cannot draw a fine map to a single locus or gene, leading to the conclusion that schizophrenia is not caused by a single factor/gene. In the second part of the article we present the oligodendrocyte-related genes that are associated with schizophrenia, as we hypothesize a potential role of oligodendrocyte-related genes in the pathology of the disorder.
Introduction
Schizophrenia is a serious and disabling mental disorder that affects approximately 1% of the general population with often devastating effects on the psychological, social and financial resources of the patient, family and larger community. The overt or positive symptoms of the disorder include auditory hallucinations, disordered thinking and delusions, while the negative symptoms include avolition, anhedonia, blunted affect and apathy. Additionally, broad areas of functioning are often disturbed including attention, memory, motivation, thought and language processes, social functioning and mood regulation.
Genes undoubtedly play an important role in the etiopathogenesis of schizophrenia. Studies of heritability using twin concordance rates, family and adoption studies, genetic linkage and allelic association analyses have demonstrated a strong genetic component underlying the predisposition to develop the illness. 1, 2 Genes influence the structure, the preservation and the activity of the neuronal processing networks of the brain 3 and are partly responsible for the numerous distorted biological and functional processes of the brain that underlie the disorder.
However, schizophrenia is not solely a genetic disorder. The concordance between monozygotic twins, although high, is not 100% and there is consistent evidence across studies of common or interactive environmental influences on liability to the disorder. 4 Hence, an intricate etiology delineated by several genes each with a small or modest effect and by nongenetic parameters (for example, epigenetic processes, environmental factors) seems more plausible. 5 Post-mortem and genetic studies that demonstrate myelin-related abnormalities in schizophrenia suggest that not only functional, but also anatomical disconnection between brain regions may be involved in the disorder. 6, 7 In this article, a description of the factors that are associated with schizophrenia is discussed in two parts. In the first part we focus on reviewing the linkage studies and susceptibility genes, so as to have an account of genetics in schizophrenia. In the second part oligodendrocyte-related genes that are involved in the pathophysiology of schizophrenia are discussed. The hypothesis is that oligodendrocytes play a major role in schizophrenia.
Linkage studies and susceptibility genes
Due to schizophrenia's multifactorial-threshold model of genetic liability, 8 it is of no surprise that no single gene or genes have been identified yet as causal for schizophrenia. Additionally, several studies have failed to replicate previous findings and positional cloning did not achieve a genome-wide level of significance, probably as a result of a combination of inadequate sample size, a low effective range of genes, tissue heterogeneity and methodological differences. 9 In spite of these difficulties and problems with replicating linkage claims, some consistent patterns have emerged in recent years.
Several independent linkage studies have suggested a number of loci where positive correlations are found repeatedly. The chromosomes with multiple overlapping findings are 1, 2, 4, 5, 6, 7, 8, 9, 10, 13, 15, 18, 22 and the X. 10 In order to identify specific disposition genes for the disorder, several researchers have undertaken detailed mapping studies of linked regions and subsequent haplotype (a combination of SNPs; single nucleotide polymorphisms). 5 The following enters into this topic more analytically.
Chromosome 1
Regions in both short (p) and long (q) arms have given positive signals in several genome scans. [10] [11] [12] One of the two major chromosomal abnormalities that have been associated with schizophrenia concerns a balanced chromosomal translocation t(1; 11) (q42; q14.3) which showed strong evidence for linkage to a broad spectrum of phenotypes comprising schizophrenia, bipolar disorder and recurrent depression. 1, 13, 14 A newsworthy finding further supporting the conditional relation of the translocation with the disorder is the prolonged latency and the reduced amplitude of auditory P300 ERP (event-related potential) shown in translocation carriers. 15, 16 Abnormal P300 is an indicator of deficient central information processing and can be used as a trait marker for the risk to develop mental disorders rather than reflecting the presence of symptoms. 16 The translocation was found to disrupt two genes on chromosome 1: disrupted-in-schizophrenia 1 and 2 (DISC1 and DISC2), respectively. 13 The DISC2 gene is antisense to DISC1, and appears not to be translated into a protein. 17 Subsequent candidate genes from this region are the translin-associated factor X (TSNAX) and the DISC1, with the latter showing promising, but not yet compelling evidence as a susceptibility gene for the disorder. 14 The TSNAX gene is a third gene in very close proximity. Another candidate gene less well replicated is the regulator of G-protein signaling 4, 18 which also maps on this chromosome and specifically on 1q23.3, a region positively associated with schizophrenia. 1, 3, 19 Recent findings also implicate the 1q32 locus for susceptibility to schizophrenia, with the presence of a candidate gene, the plexin A2 within this region which seems to be a modulator of axonal migration and neuronal plasticity. 20 Finally, a putative gene that lies on 1q23.3, the nitric oxide synthase 1 (neuronal) adaptor protein (also known as CAPON) due to its involvement in N-methyl-D-aspartate (NMDA) receptor signaling has produced rather conflicting evidence for its association with schizophrenia among studies, with a linkage disequilibrium analysis in the Chinese Han population providing positive results for an association. 21 Another study though, also using markers at the C-terminal PDZ (PDZ is an acronym combining the first letters of three proteins-post synaptic density protein (PSD95), Drosophila disc large tumor suppressor (DlgA), and zonula occuldens-1 protein (zo-l), are protein-interaction domains that are often found in multi-domain scaffolding proteins) ligand of the neuronal nitric oxide synthase gene, failed to replicate an allelic or haplotype association with schizophrenia.
22
Chromosome 2 Convergent results from several linkage and association analyses highlight the significance of chromosome 2 for the liability to schizophrenia. 10, 23 Interest in this chromosome was initiated by the report of a balanced 2:18 (q21; q23) translocation in affected individuals. 24 Moreover, a relatively recent familybased association analysis of affected children and adolescents with childhood-onset schizophrenia supports that the glutamate decarboxylase 1 gene, which lies on 2q31.1 and encodes for a g-aminobutyric acid (GABA)-synthesizing enzyme, may be a candidate risk factor for schizophrenia. 25 A neighboring gene, the distal-less homeobox 1 is also an attractive disposition gene for the disease due to its role in the differentiation of inhibitory neurons in the forebrain. 3 An intriguing association between locus 2p22.1-p13.2 schizophrenia and type 2 diabetes has been suggested, indicating a shared biological susceptibility for these two diseases. 26 
Chromosome 3
Locations of positive results on chromosome 3 have been recorded, although it is not one of the most replicated chromosomes. 10 Nevertheless it remains an interesting candidate for the genetic research of schizophrenia due to the mapping of the dopamine receptor D3 gene (DRD3) on it, a receptor that plays a role in cognitive and emotional functions. This gene has been supported as a contributor to the predisposition to schizophrenia by a meta-analysis of genetic association studies of variants with a single associated allele or genotype, in which different polymorphisms in the same gene were regarded as separate associations. 27 A follow-up linkage study, 28 using a larger number of SNP markers, reported replication of the involvement of the 3q29 locus in the liability to schizophrenia. Two linkage analyses applied on different isolated populations revealed an association between 3q and affected individuals. 29, 30 Further evidence implicating chromosome 3 in the susceptibility for the disorder comes from a positive association of affected individuals of the Han Chinese population with the cell adhesion molecule with homology to L1CAM (close homolog of L1) gene, which maps on 3p26 and seems to be involved in axonal growth and synaptic plasticity. 31 
Chromosome 4
Suggestive evidence of a linkage between schizophrenia susceptibility and the long arms of chromosome 4 also exists. 10, 12 An association study investigated for linkage disequilibrium between microsatellite markers of a region on 4p close to the locus that harbors the dopamine receptor D5 gene and major psychiatric disorders showed significant evidence of correlation with schizophrenia. 32 A current association analysis gave positive results for the involvement of the G protein-coupled receptor 78 gene, strengthening the role of chromosome 4 in the liability to schizophrenia. 33 Finally, a single case report of a de novo balanced translocation between the short arm of chromosome 4 and the long arm of chromosome 13, t(4; 13)(p16.1; q21.31) in a late-onset schizophrenic male patient has provided additional interest in this region. 34 
Chromosome 5
Several lines of evidence point to the significance of chromosome 5 in the liability to schizophrenia. 10, 12, 35, 36 A schizophrenia candidate gene, the Epsin 4, which encodes for the clathrin-associated protein enthoprotin maps on the 5q33 region. 37 This protein has a role in the transport and stability of neurotransmitter vesicles at the synapses and is probably involved in memory processes. 38 Another interesting candidate gene located at 5q21-q22 is the adenomatosis polyposis coli gene, which has been reported to confer risk for schizophrenia and may have a role in the reduced vulnerability to cancer in schizophrenia. 39 One of the most attractive candidate regions for schizophrenia on 5q31-35 that maps several GABA(A) receptor subunit genes, recently gained positive results for an association with the disorder. 40 However, further investigations are warranted considering that a concurrent study in a Japanese schizophrenic population failed to confirm this. 41 Further interest in schizophrenia susceptibility on this chromosome has been stirred by a case report of a segmental uniparental isodisomy on 5q32-qter (the offspring receives two chromosomal homologs from one parent) in a patient with childhood-onset schizophrenia. 42 
Chromosomes 6 and 7
Linkage studies have provided positive results for both arms of chromosome 6, 10,36,43 with a preliminary study also linking abnormal ocular motor performance to a locus on 6q.3. 44 One of the candidate genes identified so far with the strongest evidence in its favor, is the dystrobrevin-binding protein 1 gene which lies on 6p22. 45 Dysbindin is a component of the dystrophin protein complex in postsynaptic densities in the brain and has important roles in synaptic transmission and plasticity. 46 High-profile claims have also been made for the encoding of trace amine-associated receptor 6 gene, which maps on the 6q23.1 linkage region. 47 A current comprehensive review highlights the positive linkage and association findings regarding this chromosome. 48 The long arms of chromosome 7 have also gained strong evidence for association with schizophrenia. 10 Genetic evidence for linkage also exists for the reelin gene (RELN), which is involved in neuronal migration, axonal branching and in a signaling pathway that underlies memory formation and synaptic connectivity; 49, 50 however, the support is not strong. 51 Promising data for the gene encoding metabotropic glutamate receptor type 3, which is located on 7q21.1-q21.2 and is associated with prefrontal function, 52 supports the possibility of this gene being etiologically implicated in schizophrenia, but the evidence remains weak. 1, 3 Chromosome 8 Linked loci with schizophrenia on this chromosome have been reported mainly on the short arm, 10,12,36 but a recent linkage disequilibrium screen in a relatively isolated population found evidence for linkage regions on both arms, suggesting a wider field of research for chromosome 8. 53 On 8p21-p12 lies the second of the two most strongly implicated susceptibility genes, neuregulin1 (NRG1), 45 although other reports could not replicate this finding. 54 NRG1 is associated with synaptic remodeling, neuronal migration and brain development and appears to influence glutamatergic function through regulation of NMDA receptors. 55, 56 Further, NRG1 has been studied to have a key role in neurodevelopmental process in central nervous system (CNS) that includes oligodendrocyte development. 57 Therefore, we further discuss this important gene in more details in the second part of the article. Meanwhile, other genes at or close to this locus 58 have emerged as possible risk factors for schizophrenia by positional candidate gene analysis for example, calcineurin A-g subunit gene (PPP3CC), MSTP131.
3,56
Chromosomes 9 and 10 These two chromosomes have also gained strong evidence for association with schizophrenia. 10 A locus near the centromere of chromosome 9 might be of potential interest, due to reports of rather frequent pericentric inversions of this chromosome in schizophrenic patients. 59, 60 Furthermore, a balanced reciprocal translocation t(9, 14) (q34.2; q13) has been implicated as putative genetic contributor to schizophrenia and psychosis in general. 61 The suggestion of linkage findings on the short arm of chromosome 10 36,62 is of particular interest, because of the close agreement in location shown by different samples, using different diagnostic and analytical approaches. 10 Finally, a relatively recent publication of a genome-wide linkage scan in Ashkenazi Jewish families reported a positive linkage peak within a region that houses attractive candidate genes, such as the 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) gene and NRG3. 63 
Chromosome 11
This chromosome has shown some linkage to schizophrenia, 12 but it has not been well replicated. 10 However, this chromosome warrants some further mention as it contains the other breakpoint in the balanced 1:11 translocation and houses the brain-derived neurotrophic factor (BDNF), a putative contributory gene for the illness. 64 BDNF is an important neurotrophic factor for cortical glutamatergic pyramidal neurons. 64 Its altered expression in schizophrenia seems to influence the age of onset of the disease, the responsiveness to treatment and the parietal lobe volume in patients 64, 65 rather than the risk for schizophrenia itself. 66 The BDNF receptor TrkB has also been found to be altered by in situ hybridization assessment in the prefrontal cortex of affected individuals and has been suggested to contribute to the regulation of GABA-related gene expression and thus to an alteration in inhibitory prefrontal circuitry. 67 Moreover, an investigation of linkage disequilibrium using 444 microsatellite markers in a Japanese sample identified 11q13 as a potential liability locus for schizophrenia, adding further interest in this area. 68 
Chromosomes 13 and 14
Several molecular studies have replicated linkage locations on the long arm of chromosome 13 10, 36 and highlighted putative susceptibility genes in this area. 69, 70 The D-amino acid oxidase activator (DAOA; formerly known as G72) gene is regarded as a very promising candidate to the genetic risk for the disorder.
14 On 13q14-q21 the 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) is present, a gene that may confer risk for schizophrenia. 3 A current study however, using systematic meta-analysis of a large number of studies applying multiple methods, failed to replicate the association of the T102C polymorphism of the 5-HT2A gene with schizophrenia 71 and it seems that the positive association markers for this receptor are not consistent. 36 Even though it is not a major replicated chromosome, chromosome 14 is mentioned since it is the coexecutor of the balanced translocation t(9, 14) (q34.2; q13). It appears that the brain transcription factor neuronal PAS domain protein 3 (NPAS3) is affected by the translocation and thus has a possible role in the manifestation of psychotic symptoms. 61, 72 For other genes on this chromosome, V-AKT murine thymoma viral oncogene homolog 1 (AKT1), an arbitrator of neuronal survival in the developing brain, is a promising vulnerability gene. 14 
Chromosome 15
In the search for schizophrenias' genetic cause, this chromosome has obtained several converging positive results. 10, 36, 62 On the long arm lies an attractive candidate gene, the a7 nicotinic receptor gene (CHRNA7). 3, 64 Functional variants of this gene may be responsible for the impaired auditory sensory gating demonstrated in schizophrenic patients and many of their nonschizophrenic relatives. 73 The high ratio of tobacco smoking among patients may underlie the faultiness of the nicotinic-cholinergic system which is manifested as decreased auditory sensory gating. 74 Moreover, one could speculate that smoking is an attempt to self-medicate in schizophrenic patients. 73 An interesting study suggested an interaction between CHRNA7 and the M5 muscarinic receptor to confer susceptibility for the illness, even though the authors acknowledged the limitations of their investigation due to the utilization of a single polymorphism for each gene. 75 Nevertheless this suggestion is worthy of further investigation, considering the minor molecular evidence for the dopamine theory of schizophrenia. 36 
Chromosome 18
Variations in the DNA sequence of this chromosome seem to be associated mostly with bipolar disorder and may manifest the possible overlap between the two disorders. 10, 76 Positive linkage has been reported for 18p11, 77 a region that hosts the guanine nucleotide-binding protein (G protein) gene 78 and the nicotinamide adenine dinucleotide dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) gene. Variations of the promoter region of the NDUFV2 gene have been implicated in this conferment of risk for schizophrenia. This gene encodes a subunit of the enzyme complex 1, which catalyzes the transfer of electrons in the mitochondrial electron transport chain, hence suggesting a mitochondrial dysfunction in this disorder. 79 Convergent results regarding the mitochondrial hypothesis 80 also emerged in a largescale DNA microarray analysis of the brain region corresponding to Brodmann's area (BA) 46.
81 However, these results should be interpreted cautiously due to the possible impact of medication on the expression of mitochondria-related genes. Nevertheless, the role of chromosome 18 in the genetic predisposition to schizophrenia warrants further investigation.
Chromosome 22
Chromosome 22 is without doubt the most intensively investigated chromosome in association with schizophrenia. Highly significant evidence of linkage has emerged from many independent molecular studies. 10, 12, 30, 36 One of the most robust findings is a chromosomal aberration concerning the 22q11 deletion syndrome (also known as Di George syndrome, velocardiofacial syndrome, shprintzen syndrome and conotruncal anomaly face syndrome).
14 Affected individuals are predisposed to mental disorders, and a large study of adult patients (n = 50) estimated the increased risk for schizophrenia to be 24%. 82 Candidate genes from this area for which positive data have been reported, include catechol-O-methyltransferase (COMT), proline dehydrogenase (oxidase) 1 (PRODH) and zinc finger, DHHC-type containing 8 (ZDHHC8). 3, 13, 14 COMT is one of the two principal enzymes that degrade catecholamines such as dopamine, and there is strong evidence that it affects dopamine-mediated prefrontal information processing. 83 In regard to PRODH, a functional candidate gene that affects glutamatergic synapses, 84 a genome screening of schizophrenic individuals, in which a detailed examination of the complete genomic sequence of PRODH was performed, revealed no suggestive indication of association. 85 Nevertheless the potential involvement of this gene can not be ruled out.
Chromosome X
The increased interest in chromosome X arose from the observation that in schizophrenic patients the age of onset, symptomatology, course of illness and response to treatment are gender related. 86 Furthermore, according to an interesting theory, schizophrenia may be the result of the hominid evolution and the acquisition of language, both of which are related to brain lateralization and hemispheric dominance. 87 Anomalous cerebral asymmetry has also been reported in affected individuals at their first episode, indicating that a genetic factor is more likely to be accountable for this characteristic rather than postnatal factors or medication. 88 The speciation of humans seems to have occurred by an X-Y translocation roughly 3 Myr ago that gave rise to the Homo sapiens-specific region of Xq21.3 and Yp11.2 homology. 89 Taking into account the above observations and possibilities, several investigators have tried to find possible linkage loci and susceptibility genes for schizophrenia within the Xq21.3/Yp11.2 region of homology. 10 The results of these studies show a somewhat weak association that probably has an epigenetic background rather than arising from sequence-based variations. 90, 9 Information on the most convincing disposition genes of the aforementioned is given in Table 1 .
In order to address the limitations of the studies, two meta-analyses of schizophrenia linkage have been done, 96, 97 and obtained to some degree overlapping results. Badner and Gershon 96 relied on published data that had been analyzed using different methods and found support for the existence of susceptibility genes on chromosomes 8p, 13q and 22q for schizophrenia. On the other hand, Lewis et al. 97 applied a rank-based genome scan meta-analysis, consisting of data collected using identical methods across many studies, both published and unpublished and favored 2q. Several loci emerged: 5q, 3p, 11q, 6p, 1q, 22q, 8p, 20q and 14p (in decreasing order of significance). The 8p and 22q regions were supported by both metaanalyses. Besides the well-replicated loci, chromosomal regions that have not achieved extensive confirmation of positive linkage to the disease also emerged, such as 3p, 11q, 14p and 20q.
In one of the largest systematic genome-wide linkage scans of schizophrenia, one region in chromosome 10 satisfied genome-wide criteria for linkage and two others were highly suggestive: 17p11.2-q25.1 and 22q11. 98 Evidence for linkage of 6q15, 12q24 and 20q12, but not for 6q24-22, 1q21-22, 13q32-34 and 8p12-22 was also reported. It is notable that the region 12q24 is a novel linkage locus; 99 yet the gene encoding DAO is located close to this area and appears to be a contributory factor to the illness through its interaction with DAOA.
14 Nevertheless, further investigation of this locus is required.
The genetic linkage results seem to be replicate in some cases and in others are not. Clearly, we cannot draw a fine map to a single locus or gene. Nonetheless, these findings give evidence for the genetic basis of schizophrenia.
Oligodendrocyte-related genes associated with schizophrenia
In recent years, researchers have begun to focus on the potential role of white matter, myelin, and oligodendroglia in the pathophysiology of schizophrenia. The cognitive dysfunctions of schizophrenic patients may be the result of a functional disconnection in both local neural circuitry and that spanning several brain areas. 100 Hence, schizophrenia may be viewed as a disconnectivity syndrome 100, 101 due to disturbances in myelination, with the aberrant white fasciculi leading to impairment of electrical insulation of nerve axons and consequently, to abnormal transfer of electrical currents along the axons and of information across the brain regions. 102 In order to substantiate this theory, DNA microarray analyses have been performed in post-mortem brain regions of patients and healthy individuals in an attempt to investigate the differential expression of myelinrelated genes.
In a microarray analysis 7 of post-mortem tissue from the dorsolateral prefrontal cortex, which has been implicated in the pathology of schizophrenia, 103 more than 6500 genes were compared from 12 chronic schizophrenic and 12 control subjects, and of these, 89 genes met criteria for altered expression in schizophrenia. Of these 89 genes, only 17 were decreased in schizophrenia and 6 of these were related to myelin and/or oligodendrocytes. The downregulated genes were myelin and lymphocyte protein found in chromosome 2qcen-13, 2 0 ,3 0 -cyclic nucleotide 3 0 phosphodiesterase (CNP) in chromosome 17q21, myelin-associated glycoprotein (MAG) in chromosome 19q13.1, transferring in chromosome 3q21, gelsolin in chromosome 9q33-34, and the v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (also known as HER3), a neuregulin receptor (96) . As mentioned before, NRG1 has a key role in neuronal migration and specification, 104, 105 GABA and glutamate receptor expression 106 and in synaptogenesis and synaptic plasticity in the CNS. 107 Further, it shows trophic and mitogenic effects in oligodendrocyte progenitor cell (OPC) cells in vitro.
108
NRG1 null mice were found to be deficient in development of OPC. 109 NRG is important in oligodendrocyte development and maintenance in which it directly/indirectly plays a role in the etiology of schizophrenia. Corfas et al., 110 have proposed a molecular and cellular basis of NRG1-erbB: NRG1 regulates radial glia formation, neuronal migration, neurotransmitter receptor expression, oligodendrocyte development and myelination; thus, it might be the intermediate molecule to block any of these to develop schizophrenia as it is observed in 3 and localized in mitochondria, cytoplasm, nuclei, neuritis and plasma membranes Interacts with centrosome and cytoskeletal proteins, proteins that are involved in membrane trafficking of receptors, signal transduction proteins and possibly proteins with association in mitochondrial function 93 The presence of DISC in multiple types of synapses is suggestive of its involvement in corticocortical and thalamocortical connections 17 Affects neuronal migration, neurite architecture and intracellular transport 1 Allelic variations are overtransmitted in schizophrenia 93 The Ser allelic is associated with altered hippocampal structure and function in healthy subjects 93 The mutation of DISC1 fails to bind to NUDEL, a protein essential for cortical development, neuronal migration and axon growth 1 Evidence for enhanced nuclear DISC1 protein expression in schizophrenic brain 13 
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COMT 22q11.2 Encodes for an enzyme that catalyzes the methylation of dopamine, norepinephrine and catecholoestrogens 3 Exists in membrane-bound (MB) (in human brain) and soluble (S) (in peripheral tissues and in rodents) forms. The MB-COMT has greater affinity for dopamine 3 Is more abundant in the prefrontal cortex and hippocampus than in the striatum or in brainstem dopamine neurons 3 Is implicated in cortical interneuronal monoaminergic signaling and associated with functions in the PFC 3 Prefrontal neurons inhibit striatal DA projections, presumably through GABAergic interneurons 64 Via the many links between dopamine and amino-acid transmitter systems, it might affect other synaptic populations, including glutamatergic ones 5 One of the COMT SNPs, the val158met allele impacts on the stability of the enzyme (val-COMT has lower activity than met-COMT) 3 Val158met impacts upon level of COMT mRNA (greater in the deep than superficial laminae) 3 Frequent association between the val allele and illness (it confers higher activity and thermal stability to COMT) 1, 3 The Val/Met polymorphism is associated with reduced performance in tests of frontal lobe function 1 The Val allele may generate cortical dopamine deficiency and mesolimbic hyperdopaminergia in schizophrenia 3 A recent meta-analysis reports no evidence for association with the val allele 94 COMT is more strongly associated with schizophrenic female patients 3 9 PRODH 22q11.2 Is a mitochondrial enzyme and is involved in the energy transfer 95 Influences the regulating of proline levels, which in turn influence glutamate metabolism and release 1, 3 Evidence of associations of PRODH SNPs with the disorder 5 The pseudogene of PRODH2 contains some of the missense SNPs that are associated with the disorder; the PRODH2 variation might be the result of conversion between the real and pseudogene sequences 3 The PRODH knockout mouse has abnormalities of sensorimotor gating similar to those in schizophrenia schizophrenic patients. Information on these genes and their functions is given in Table 2 .
Other gene families were also found to be altered in this microarray study, 7 including genes involved in brain development and plasticity, neurotransmission and receptors, GABA signaling, the cytoskeleton, channels and transporters. MAG has been suggested as a susceptibility gene for the disorder by other independent studies, in which a positive association was found between the gene and schizophrenic patients in the Chinese Han population. 119, 120 Consistent evidence for an oligodendrocyte dysfunction in the disease also emerged from two other studies, in which levels of gene expression were assessed in the prefrontal cortices of schizophrenic patients. 121, 118 Tkachev et al. 118 further reported significant downregulation of proteolipid protein1 (PLP1), which maps at chromosome Xq21.3-q22 and mediates axonal-glial interactions, oligodendrocyte transmembrane protein (CLDN11), which is the third most abundant myelin protein in the CNS after PLP1 and myelin basic protein (MBP). MBP was also found to be downregulated. The reduced levels of MBP (it functions as a microtubule-stabilizing protein in mature oligodendrocytes 122 ) attain further support from a study that evaluated its expression in the hippocampus and found it to be decreased in female subjects with schizophrenia. 123 Moreover, an investigation of the myelin proteins with nonequilibrium gel electrophoresis, 124 a technique that reveals myelin proteins (MBP, proteolipids and basic Wolfgram proteins) and many other unidentified major basic proteins, reported equivalent results. Further evidence for the downregulation of PLP1 in schizophrenic individuals comes from a family-based association study in 487 Chinese Han family trios. 125 Myelin oligodendrocyte glycoprotein (MOG), which is both a target antigen for myelin-destructive antibodies in autoimmune CNS demyelization disorders and a cellsurface marker for oligodendrocyte maturation, was also shown to be downregulated in the study by Tkachev et al. 118 and in Han Chinese samples. 126 However, no evidence for association with schizophrenia was reported for MOG in Caucasian samples. 127 In addition, Tkachev studied oligodendrocyterelated genes that differentiate between mature and progenitor cells (that is, platelet-derived growth factor receptor and NG2 proteoglycan). He reported that neither gene was changed in schizophrenia, suggesting that the downregulation of the myelin-associated genes addresses mature oligodendrocyte marker genes. Moreover these genes encode for proteins, which are located in the major dense line of myelin and represent transmembrane-spanning proteins. Hence, this downregulation might lead to a defect in myelin compaction. 118 Abnormalities in the expression of myelination-related genes in the prefrontal cortex of affected individuals have also been reported. 128 Downregulation of several of the oligodendrocyterelated genes has also been shown in a genome-wide screen of the temporal cortex (middle temporal gyrus corresponding to BA21). 102 In this interesting study, the finding of a reduced expression of the period homolog 1 gene (known as circadian pacemaker protein gene) introduces the notion of an abnormal circadian rhythm in schizophrenia and should inspire further investigation.
Replicated results also come from Aberg et al., 129 who examined tissue samples from the frontal cortex, BA8 and the left side of the frontal gyrus. In a microarray analysis conducted by Dracheva et al., 130 the mRNAs of MAG, CNP, SOX10 (sex-determining region Y-box containing gene 10), CLDN11 and peripheral myelin protein 22 were reduced in the hippocampus and anterior cingulate cortex, but not in the putamen of patients with schizophrenia. These findings support the notion that the altered expression of oligodendrocyte and myelin-related genes in schizophrenia is brain region-specific rather than global, which would indicate a cellular functional impairment rather than a loss of oligodendrocytes. 118, 129, 131 In a remarkable molecular study by Katsel et al.,
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gene expression was analyzed in multiple cortical regions as well as in the hippocampus, caudate nucleus and putamen of post-mortem schizophrenic and control brain samples. The most altered transcripts were those encoding for proteins involved in determination of glial delineation, myelin structure and adhesion proteins participating in axoglial contacts. These abnormalities in schizophrenic brains were most pronounced in the hippocampus, superior temporal and cingulate cortices. Confirmation of these gene expression abnormalities in several independent studies 102, 129, 132 with different brain samples and techniques provides very strong evidence for oligodendrocyte dysfunction in schizophrenia.
Another critical gene for the etiopathogenesis of schizophrenia is Nogo (also known as reticulon 4, RTN4, NI 250 or RTN-X), a myelin-associated protein which inhibits the outgrowth of neurites and nerve terminals. 133 It maps on chromosome 2p13-14, a locus strongly associated with schizophrenia 97 and is expressed by oligodendrocytes in CNS-myelinated tissues during neurodevelopment. 134 Novac et al. reported that the mRNA of Nogo was overexpressed in the frontal cerebral cortex of schizophrenic patients, 135 suggesting a role for Nogo in abnormal neuronal organization in schizophrenia. Although subsequent studies 136, 137 failed to replicate the association with the polymorphism in Nogo, an investigation by Tan et al. 138 reported a gender-specific association of the polymorphism with schizophrenia. In addition, Covault et al. failed to replicate Novak's results, but showed a racial difference in the frequency of the polymorphism. 139 Novak reevaluated the results of her previous investigation, using a more accurate method, a larger set of matched samples, and found an upregulation of the isoform Nogo C in schizophrenia. 140 Convergent evidence for the role of the Nogo gene in schizophrenia also comes from Is not present in compact myelin 111 May play a role in the modulation of cell-surface morphology 111 Interacts with mitochondria 117 and has a role in intracellular communication and signal transduction cascade 111 Is associated with myelin formation and maintenance 111 Is subject to cis-acting influences on gene expression 117 Knocked out mice to CNP gene display central nervous system pathological characteristics reminiscent of some features observed in schizophrenia (reduction in overall brain size, enlarged ventricles, and corpus callosum atrophy) 117 
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TF 3q21 An iron-transport protein, not specific to the CNS 141 This gene encodes for a functional cell-surface receptor, a GPI-linked protein, which is implicated in axonal growth inhibition. 141 It maps on chromosome 22q11.2, within the velocardiofacial syndrome's locus, and mutations of the RTN4R are associated with the disorder. Besides Nogo, two other myelin proteins bind to the RTN4R: MAG and MOG, which have already been shown to be related to schizophrenia. 112 Hence, both Nogo and its receptor may be relevant to the pathophysiology of the disorder.
The human quaking gene, called quaking homolog KH domain RNA binding (mouse) (QKI), has also emerged as a potential susceptibility factor, considering that it is suspected of regulating the alternative splicing of MAG, PLP1 and MBP in mice. The function of QKI has not been studied in humans, but the mouse homolog is involved in neural development and myelination. 142 Aberg et al. 129 demonstrated that disturbed expression levels of six oligodendrocyte-related genes MAG, MBP, PLP1, TF, SOX10 and CDKN1B were strongly associated with disrupted relative expression of two splice variants QKI-7kb and QKI-7kb B in patients. This suggests that alteration of QKI-7kb might be the primary cause of the down-regulation of myelin-related genes observed in schizophrenia. Subsequently, the QKI gene is suspected of regulating oligodendrocyte differentiation and maturation, and of influencing the myelin process in the brain. Mutations within the gene in its regulatory elements or on other genes regulated by QKI may lead to disease manifestation in humans. 143 The involvement of the functional variants of the QKI gene in the increase of susceptibility to schizophrenia is further corroborated by its locus; it maps on chromosome 6q25-6q27, a region that is strongly associated with vulnerability to the disorder. 97, 144 The role of these genes in the susceptibility to schizophrenia derives added weight from a number of genetic linkage studies that confirm linkage of the disease to specific loci for these genes.
12,145-148 Still we need more in-depth studies to completely reveal the molecular biology of schizophrenia.
Further evidence for the role of oligodendrocytes and myelin in schizophrenia
There is evidence that patients with velocardiofacial syndrome, a good genetic model for investigations of schizophrenia, demonstrate reduced white matter anisotropy in frontal, parietal and temporal regions, as well as in tracts connecting the frontal and temporal lobes, implicating an influence of 22q11.2 deletion on white matter circuitry. 149 Moreover, myelination of the prefrontal cortex has been observed to occur in late adolescence and early adulthood, which is typically the age of onset of schizophrenia, 7, 118, 123 providing an indication of the importance of myelination for the continued maturation and normal functioning of the brain and the role of dysmyelination for the pathological pathways of the disorder.
Magnetic resonance imaging (MRI) findings in patients diagnosed with schizophrenia include lateral ventricle enlargement, medial temporal lobe volume reduction, neocortical superior temporal gyrus volume reduction, frontal and parietal lobe abnormalities, global and regional reduction in white matter volume and subcortical abnormalities affecting the basal ganglia, corpus callosum, thalamus and cerebellum. 150, 151 These findings suggest the involvement of a large number of functionally related brain regions. The most frequent positive findings in schizophrenia studies are decreased fractional anisotropy (FA), along with increased diffusivity within prefrontal and temporal lobes, as well as abnormalities within the fiber bundles connecting these regions (including uncinate fasciculus, cingulum bundle and arcuate fasciculus). 152 Altered FA values in the splenium of the corpus callosum in affected individuals 153, 154 and internal capsule diffusion abnormalities 155 have been detected. Moreover, differences in the cerebellar peduncles in schizophrenia compared to controls have been demonstrated with a decrease of the FA in schizophrenia subjects. 114, 156 Two studies have reported widespread diffusion abnormalities in parietal, temporal, prefrontal and occipital white matter. 116, 157 The above findings from several imaging studies provide evidence that the major cognitive disturbances in schizophrenic patients possibly result from deficits of myelination in relevant neuronal structures (for example, corpus callosum) and the resulting disturbances of signal transduction within these structures.
Epigenetics: the meeting point of genes and environment
In the race to uncover the pathology of schizophrenia, gene researchers, taking into consideration that the expression of oligodendrocyte genes is regulated by a combination of oligodendrocyte-specific transcription factors, 158 have focused on investigating these transcription factors. Coordinate synthesis of myelin is transcriptionally mediated, so it is important to examine whether these transcription factors show abnormal mRNA imprinting. Downregulated expression levels were shown for the transcription factors oligodendrocyte transcription factor 1 and oligodendrocyte lineage transcription factor 2, and the high mobility group protein SOX10, which is crucial for the final differentiation of oligodendrocytes. 118, 159 It is worth mentioning that SOX10 lies within a strong susceptibility locus for schizophrenia on chromosome 22q11-13. Expression of several major myelin genes, including PLP1 and MBP, is believed to be under SOX10 transcriptional control. 118, 159 In a current study though, it was concluded that the DNA-sequence variations of the SOX10 gene do not contribute to susceptibility to schizophrenia. 160 The same group of scientists demonstrated that the DNA methylation status of SOX10 accounts for its downregulation and oligodendrocyte dysfunction in schizophrenia. 158 The reduced expression of the gene was correlated with an increased percentage of the methylated allele in brains of patients with schizophrenia. Hypermethylation is known to correlate with the silencing of gene expression and transcriptional inactive chromatin contains-methylated cytosines. 158, 161, 162 Aligned to this finding, it has also been suggested that enhanced DNA methylation of the RELN 49, 50, 162 and COMT promoters 161 is involved in their downregulation in schizophrenia. These studies indicate that hypermethylation of the promoter of the genes could provide a molecular basis for the genes' hypoactivity in schizophrenia. 49 DNA methylation status, as well as chromatin remodeling, histone deacetylation and RNA inhibition and modification represent epigenetic mechanisms. [163] [164] [165] Epigenetics represent a secondary inheritance but also a reversible system, 95, 166 that is suggested as an etiopathogenic factor for complex mental disorders, such as schizophrenia. 167 Alterations in DNA methylation might indicate a mechanism for DNA flexibility and short-term adjustment that enables cells to record the past under various environmental conditions. 49 Potential causes of pathological DNA hypermethylation which have been indicated as risk factors for schizophrenia include some environmental insults, such as ephemeral ischemia with a consequent increase of DNA methylation, nitric oxide, which has neurodegenerative effects in focal ischemia, intrauterine environmental conditions and maternal malnutrition, alcohol abuse during pregnancy, birth and obstetric complications, as well as exposure to drugs and chemicals, hormonal status (for example, estradiol, estrogen, steroid hormones) and viral infections. 49, 165, 168 Besides the above data, 49, 158, 161, 162 reported downregulation of histone deacetylase 3 in the temporal cortex of patients with schizophrenia 102 and epigenetic variations in the genes for serotonin 2A (HTR2A) and the dopamine D3 (DRD3) and D2 (DRD2) receptors 163, 169 provide further supplementary evidence for the contribution of epigenetic misregulation in schizophrenia. Interestingly, the finding of different degrees of methylation of the promoter area of DRD2 between the right and left striatum 169 introduces the possibility that the epigenetic mechanisms play a role in brain hemisphere laterality 165 and provides a new interpretation of the reported anomalous cerebral asymmetry in affected individuals. The epigenetic hypothesis provides a new perspective on the etiopathogenesis of schizophrenia and on the various non-Mendelian characteristics of the disease, such as the presence of clinically indistinguishable sporadic and familial cases, phenotypic variance, discordance of monozygotic twins, coincidence of peaks of disease onset with major endocrine rearrangements and the fluctuating course of disease severity. 167 
Gene expression and drug treatment
A very interesting and important finding in the investigation of Aberg et al. 142 is that the medication used by patients caused additional modifications in mRNA levels of QKI: Schizophrenic patients treated with typical neuroleptics had higher mRNA levels of the genes' variants than untreated schizophrenic patients or patients treated with atypical neuroleptics. This result implies an unknown effect of this class of drugs on the transcription initiation of the QKI gene, which may have downstream consequences for the myelination pathway. 142 Even though medication is not implicated in the observed alterations in gene expression in schizophrenia in several studies, 7, 128 the possibility that the expression levels of some genes may be modulated by medication 128, 158 cannot be ruled out because of the small sample size of schizophrenic patients off medication that is used for this kind of analyses. This issue must be investigated more intensely and with a larger sample of medication-naive patients, in order to obtain statistically sound results.
Conclusions
The decipherment of the genetic aspects of schizophrenia, one of the most devastating and complex mental disorders, has reached a turning point. Several linkage findings in schizophrenia have been replicated and followed by systematic fine-mapping efforts to identify positional susceptibility genes. These genes are involved in a number of biological processes, including synaptic plasticity, neuronal development, neurotransmission and signal transduction. 7 The vast number of reported linkage loci and putative genes mapping on them should not be considered as a failure of genetics to shed more light on the etiopathogenesis of schizophrenia. On the contrary, they provide evidence for the genetic background of the disorder and highlight the necessity of applying more advanced techniques, utilizing more comprehensive sets of genetic markers, more accurate genome sequences, larger samples with less broad diagnostic categories, drug-naive patients or patients with matched drug treatment profiles and more advanced statistical procedures.
Implication of oligodendroglia and myelin in schizophrenia derives from multiple research findings. Imaging and neurocytochemical evidence, similarities with demyelization diseases, age-related changes in white matter and myelin-related gene abnormalities demonstrated in schizophrenic brains have been examined in light of the hypothesis that oligodendroglial dysfunction with subsequent abnormalities in myelin maintenance and repair contribute to the schizophrenic syndrome. 101 Finally, investigations of the epigenetic mechanisms involved in the regulation of the expression of the genes and not only the DNA-sequence variation might help our understanding of the etiopathological pathways of schizophrenia.
Drugs modulating oligodendrocyte survival and differentiation, as well as epigenetic mechanisms are likely to open the way to the discovery of new therapies that can be beneficial for schizophrenic patients.
Future research strategies should entail the investigation of putative correlations between structural brain abnormalities and information-processing deficits as assessed by electroence phalogram (EEG) and ERPs. By applying diffusion-weighted MRI scientists are capable of assessing the FA of the fibers of the whole brain, as an indirect marker of the microstructural properties of white matter. Based on cerebral EEG and ERPs, investigators are able to assess putative abnormal interhemispheric communication for schizophrenic subgroups by investigating the interhemispheric synchronization of different EEG frequencies and several processes in brain with ERPs. Future evidence of correlations between the functional deficits that characterize the syndrome and neuroimaging structural abnormalities, as well as genetic findings related to these processes or structures will facilitate in making less ambiguous the pathogenesis of schizophrenia.
